药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Zopiclone
Technetium Tc-99m sestamibi
The serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Lenvatinib
The serum concentration of Lenvatinib can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Umeclidinium
The serum concentration of Umeclidinium can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Ceritinib
The serum concentration of Ceritinib can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Sofosbuvir
The serum concentration of Sofosbuvir can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Dolutegravir
The serum concentration of Dolutegravir can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Dabrafenib
The serum concentration of Dabrafenib can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Pomalidomide
The serum concentration of Pomalidomide can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Brentuximab vedotin
The serum concentration of Brentuximab vedotin can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Bendamustine
The serum concentration of Bendamustine can be increased when it is combined with Dabigatran etexilate.
Zopiclone
Cefamandole nafate
The therapeutic efficacy of Dabigatran etexilate can be decreased when used in combination with Cefamandole nafate.
Zopiclone
Umifenovir
The metabolism of Dabigatran etexilate can be decreased when combined with Umifenovir.
Zopiclone
Fosphenytoin
The metabolism of Dabigatran etexilate can be decreased when combined with Fosphenytoin.
Zopiclone
Olaparib
The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Olaparib.
Zopiclone
Cepeginterferon alfa-2B
The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Cepeginterferon alfa-2B.
Zopiclone
Peginterferon beta-1a
The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Peginterferon beta-1a.
Zopiclone
Dinutuximab
The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Dinutuximab.
Zopiclone
Blinatumomab
The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Blinatumomab.